The patient, identified as R12 in inspection records, had tested positive for Clostridium difficile on August 18. The bacterial infection causes severe diarrhea and can be life-threatening in elderly patients.
R12's physician ordered Fidaxomicin, a specialized antibiotic for C-diff treatment, on August 19. The pharmacy said the medication wasn't available.
The doctor switched to Vancomycin, another antibiotic used to treat the infection. The pharmacy promised delivery on August 20.
The medication never came.
By August 21, R12 still hadn't received the Vancomycin. That day, the resident was hospitalized for C-diff management.
R12 had been admitted to Pine Crest Health and Memory Care on June 5 with a history of recurring C-diff infections. The resident's original physician orders included Vancomycin every six hours "until Fidaxomicin is available on or near 08/21/25."
Federal inspectors found the pharmacy breakdown violated requirements that nursing homes provide "regular and reliable pharmaceutical service" to residents. The facility's own policy manual promised "routine and timely pharmacy services six days per week and emergency pharmacy services 24 hour per day, seven days per week."
Multiple nurses told inspectors the pharmacy problems weren't isolated to R12's case.
Registered Nurse G said she was "having difficulty getting medications in a timely manner from pharmacy at times." On the day of her interview, August 26, an insulin pen was supposed to be delivered but hadn't arrived.
Registered Nurse I described ongoing communication problems with the pharmacy. "Recently there was an issue with the pharmacy stating they did not receive faxed orders, but the pharmacy is able to see them in the computer program also and is still not sending them on time," she told inspectors.
RN I had personally called the pharmacy to order R12's medication. She confirmed the Fidaxomicin wasn't available and Vancomycin was ordered instead, with delivery promised for the afternoon of August 20.
Licensed Practical Nurse H said she'd "been having difficulty getting refill medications for residents" recently. She blamed "program issues" that left pharmacy staff unable to look up orders.
C. difficile infections are particularly dangerous in nursing home settings. The bacteria spreads through spores that survive on surfaces and can cause outbreaks affecting multiple residents. Prompt antibiotic treatment is essential to prevent complications including toxic megacolon, intestinal perforation, and death.
Vancomycin is considered a standard treatment for C-diff when newer medications like Fidaxomicin aren't available. The antibiotic must be taken every six hours to maintain therapeutic levels in the bloodstream.
R12 had been living with recurring C-diff infections since at least June, when the resident was admitted with "enterocolitis related to recurring clostridium difficile infection." The August positive test represented another flare-up of the chronic condition.
The inspection report doesn't specify how long R12 remained hospitalized or whether the resident returned to Pine Crest. It also doesn't identify which pharmacy serves the facility or detail what steps administrators took to address the delivery failures.
The medication delays affected other residents beyond R12. Nurses described a pattern of pharmacy problems that left them scrambling to obtain basic medications including insulin for diabetic patients.
The facility's pharmacy policy explicitly requires emergency services around the clock, seven days a week. Yet when R12 needed urgent antibiotic treatment for a potentially life-threatening infection, the system failed completely.
Federal inspectors classified the violation as causing "minimal harm or potential for actual harm" affecting "few" residents. But for R12, the pharmacy's inability to deliver a common antibiotic meant the difference between treatment at the nursing home and emergency hospitalization.
The inspection took place August 27, following a complaint. R12's hospitalization occurred sometime between August 21 and the inspection date, though the exact timeline isn't specified in the report.
Pine Crest Health and Memory Care now faces federal oversight to correct its pharmaceutical services. The facility must demonstrate it can reliably obtain and deliver medications residents need, when they need them.
For R12, that assurance came too late.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Pine Crest Health and Memory Care from 2025-08-27 including all violations, facility responses, and corrective action plans.
Additional Resources
- View all inspection reports for Pine Crest Health and Memory Care
- Browse all WI nursing home inspections